These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17392047)

  • 1. Biphasic fracture risk in diabetes: a population-based study.
    Leslie WD; Lix LM; Prior HJ; Derksen S; Metge C; O'Neil J
    Bone; 2007 Jun; 40(6):1595-601. PubMed ID: 17392047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen use and osteoporotic fracture risk: a population-based analysis.
    Cooke AL; Metge C; Lix L; Prior HJ; Leslie WD
    J Clin Oncol; 2008 Nov; 26(32):5227-32. PubMed ID: 18838712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of hip fractures in older individuals with diabetes: a population-based study.
    Lipscombe LL; Jamal SA; Booth GL; Hawker GA
    Diabetes Care; 2007 Apr; 30(4):835-41. PubMed ID: 17392544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does diabetes increase the risk for fractures after solid organ transplantation? A nested case-control study.
    Rakel A; Sheehy O; Rahme E; Lelorier J
    J Bone Miner Res; 2007 Dec; 22(12):1878-84. PubMed ID: 17680725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk after parathyroidectomy among chronic hemodialysis patients.
    Rudser KD; de Boer IH; Dooley A; Young B; Kestenbaum B
    J Am Soc Nephrol; 2007 Aug; 18(8):2401-7. PubMed ID: 17634437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risks of hip fracture in diabetic patients of Taiwan: a population-based study.
    Chen HF; Ho CA; Li CY
    Diabetes Care; 2008 Jan; 31(1):75-80. PubMed ID: 17947342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program.
    Hodsman AB; Leslie WD; Tsang JF; Gamble GD
    Arch Intern Med; 2008 Nov; 168(20):2261-7. PubMed ID: 19001204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fracture risk from psychotropic medications: a population-based analysis.
    Bolton JM; Metge C; Lix L; Prior H; Sareen J; Leslie WD
    J Clin Psychopharmacol; 2008 Aug; 28(4):384-91. PubMed ID: 18626264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of fractures in a cohort of veterans with chronic multiple sclerosis or traumatic spinal cord injury.
    Logan WC; Sloane R; Lyles KW; Goldstein B; Hoenig HM
    Arch Phys Med Rehabil; 2008 Feb; 89(2):237-43. PubMed ID: 18226646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The population risk of fractures attributable to oral corticosteroids.
    Donnan PT; Libby G; Boyter AC; Thompson P
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):177-86. PubMed ID: 15672413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.
    Perreault S; Dragomir A; Blais L; Moride Y; Rossignol M; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):248-59. PubMed ID: 18213734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program.
    Leslie WD; Tsang JF; Lix LM
    Bone; 2008 Oct; 43(4):667-71. PubMed ID: 18602504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2009 Jan; 84(1):45-55. PubMed ID: 19067021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors.
    Kaye JA; Jick H
    Pharmacotherapy; 2008 Aug; 28(8):951-9. PubMed ID: 18657011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark.
    Vestergaard P; Rejnmark L; Mosekilde L
    Scand J Public Health; 2006; 34(4):371-7. PubMed ID: 16861187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study.
    Tsiropoulos I; Andersen M; Nymark T; Lauritsen J; Gaist D; Hallas J
    Epilepsia; 2008 Dec; 49(12):2092-9. PubMed ID: 18479399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hip fractures in the elderly in Israel-possible impact of preventable conditions.
    Segal E; Raichlin V; Rimbrot S; Zinman C; Raz B; Ish-Shalom S
    Arch Gerontol Geriatr; 2009; 48(2):182-5. PubMed ID: 18294711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low bone mineral density and fracture burden in postmenopausal women.
    Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
    CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture risk in patients treated with loop diuretics.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Intern Med; 2006 Jan; 259(1):117-24. PubMed ID: 16336519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.